Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials: where are we now?

Stuart J Knechtle1

  • 1Division of Organ Transplantation, Department of Surgery, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792-7375, USA. stuart@tx.surgery.wisc.edu

Immunological Reviews
|November 18, 2003
PubMed
Summary

Achieving true immunologic tolerance in kidney transplantation remains a challenge, despite clinical trials improving graft survival and reducing side effects. Research continues to explore strategies for minimizing immunosuppression and preventing rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Back-to-base Versus In-transit Machine Perfusion in Donation After Circulatory Death Liver Transplantation: Insights From a National Registry.

Transplantation direct·2026
Same author

A highly sensitive issue: Helping sensitized patients requires greater regulatory flexibility.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Normothermic Regional Perfusion in Organ Procurement: Do the Kidneys Benefit?

Annals of surgery·2026
Same author

Profiling Allogeneic HLA-specific B-cell Responses Utilizing a 64-plex Single-HLA Reporter Cell Panel.

bioRxiv : the preprint server for biology·2026
Same author

Evolution of out-of-sequence liver allocation, 2019-2024.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

A novel immunoglobulin G- and immunoglobulin cleaving enzyme MG (IceMG), for antibody-mediated rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025

Area of Science:

  • Nephrology
  • Transplant Immunology
  • Clinical Trials

Background:

  • Renal transplantation outcomes have improved, yet achieving complete immunologic tolerance is rare.
  • Current clinical trials aim for 'prope tolerance' by minimizing immunosuppressants like steroids and calcineurin inhibitors.
  • New immunosuppressive agents are investigated for efficacy and reduced toxicity.

Purpose of the Study:

  • To review lessons learned from clinical trials in renal transplantation.
  • To illustrate clinical trial scenarios using case presentations from the University of Wisconsin.
  • To outline future directions for achieving tolerance in kidney transplant patients.

Main Methods:

  • Case presentation style using actual patient cases from the University of Wisconsin.

Related Experiment Videos

  • Summarizing lessons learned from individual patient experiences.
  • Referencing relevant literature to support case-based findings.

    • Main Results:

    • Clinical trials have significantly improved graft survival over 30-40 years.
    • Infectious and malignant side effects have been lowered.
    • True immunologic tolerance remains largely unachieved due to various factors.

    Conclusions:

    • Case studies highlight key lessons from renal transplant clinical trials.
    • Despite advancements, achieving complete tolerance in kidney transplant recipients is still a distant goal.
    • Future research should focus on strategies to overcome barriers to true tolerance.